{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:36:39Z","timestamp":1778625399166,"version":"3.51.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82203377"],"award-info":[{"award-number":["82203377"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473238"],"award-info":[{"award-number":["82473238"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhejiang natural science foundation of China","award":["LQ22H160036"],"award-info":[{"award-number":["LQ22H160036"]}]},{"name":"Zhejiang natural science foundation of China","award":["LY24H160022"],"award-info":[{"award-number":["LY24H160022"]}]},{"name":"Zhejiang Health Science and Technology Project","award":["2025KY031"],"award-info":[{"award-number":["2025KY031"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03153-x","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T17:12:38Z","timestamp":1747933958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["LZTS2 methylation as a potential diagnostic and prognostic marker in LIHC and STAD: Evidence from bioinformatics and in vitro analyses"],"prefix":"10.1038","volume":"15","author":[{"given":"Xiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luanluan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Nan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyi","family":"Shou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailong","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"issue":"3","key":"3153_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"3153_CR2","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2021. CA Cancer J Clin. 71(1), 7\u201333 (2021).","journal-title":"CA Cancer J Clin."},{"issue":"4","key":"3153_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay, J. et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 149(4), 778\u2013789 (2021).","journal-title":"Int J Cancer."},{"key":"3153_CR4","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.22.00142","volume":"7","author":"M Tufail","year":"2023","unstructured":"Tufail, M. & Wu, C. Cancer statistics in Pakistan from 1994 to 2021: Data from cancer registry. JCO Clin. Cancer Inform. 7, e2200142 (2023).","journal-title":"JCO Clin. Cancer Inform."},{"issue":"41","key":"3153_CR5","first-page":"53","volume":"3","author":"J Balogh","year":"2016","unstructured":"Balogh, J. et al. Hepatocellular carcinoma: A review Journal of Hepatocellular. Carcinoma. 3(41), 53 (2016).","journal-title":"Carcinoma."},{"key":"3153_CR6","unstructured":"Network NCC. Gastric Cancer. NCCN clinical practice guidelines in oncology ,2023."},{"issue":"1\u20132","key":"3153_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11010-010-0599-y","volume":"346","author":"JM Kim","year":"2011","unstructured":"Kim, J. M. et al. Effect of the modulation of leucine zipper tumor suppressor 2 expression on proliferation of various cancer cells functions as a tumor suppressor. Mol. Cell Biochem. 346(1\u20132), 125\u2013136 (2011).","journal-title":"Mol. Cell Biochem."},{"issue":"6","key":"3153_CR8","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1074\/jbc.M112.417568","volume":"288","author":"DT Johnson","year":"2013","unstructured":"Johnson, D. T. et al. Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development. J. Biol. Chem. 288(6), 3727\u20133738 (2013).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"3153_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41418-024-01328-z","volume":"32","author":"L Xu","year":"2025","unstructured":"Xu, L. et al. Disrupting CCDC137-mediated LZTS2 and \u03b2-TrCP interaction in the nucleus inhibits hepatocellular carcinoma development via \u03b2-catenin and AKT. Cell Death Differ. 32(1), 134\u2013148 (2025).","journal-title":"Cell Death Differ."},{"key":"3153_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104844","volume":"98","author":"G Usui","year":"2023","unstructured":"Usui, G. et al. Integrated environmental, lifestyle, and epigenetic risk prediction of primary gastric neoplasia using the longitudinally monitored cohorts. EBioMedicine 98, 104844 (2023).","journal-title":"EBioMedicine"},{"issue":"1","key":"3153_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12957-018-1349-y","volume":"16","author":"Z Shen","year":"2018","unstructured":"Shen, Z. et al. LZTS2 promoter hypermethylation: A potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma. World J. Surg. Oncol. 16(1), 42 (2018).","journal-title":"World J. Surg. Oncol."},{"issue":"8","key":"3153_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar, D. S. et al. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19(8), 649\u2013658 (2017).","journal-title":"Neoplasia"},{"issue":"1","key":"3153_CR13","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s12864-015-1847-z","volume":"16","author":"A Koch","year":"2015","unstructured":"Koch, A., De Meyer, T., Jeschke, J. & Van Criekinge, W. MEXPRESS: Visualizing expression, DNA methylation and clinical TCGA data. BMC Genomics 16(1), 636 (2015).","journal-title":"BMC Genomics"},{"issue":"Suppl 5","key":"3153_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12920-019-0514-7","volume":"12","author":"SJ Park","year":"2019","unstructured":"Park, S. J., Yoon, B. H., Kim, S. K. & Kim, S. Y. GENT2: An updated gene expression database for normal and tumor tissues. BMC Med. Genomics. 12(Suppl 5), 101 (2019).","journal-title":"BMC Med. Genomics."},{"issue":"21","key":"3153_CR15","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li, T. et al. TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 77(21), e108\u2013e110 (2017).","journal-title":"Cancer Res."},{"issue":"W1","key":"3153_CR16","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45(W1), W98\u2013W102 (2017).","journal-title":"Nucleic Acids Res."},{"key":"3153_CR17","doi-asserted-by":"crossref","unstructured":"Bartha, \u00c1ron, and Bal\u00e1zs Gy\u0151rffy. TNMplot. com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. International journal of molecular sciences 22.5 (2021): 2622.","DOI":"10.3390\/ijms22052622"},{"issue":"5","key":"3153_CR18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2(5), 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"issue":"1","key":"3153_CR19","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/nar\/gkg034","volume":"31","author":"CV Mering","year":"2003","unstructured":"Mering, C. V. et al. STRING: A database of predicted functional associations between proteins. Nucleic Acids Res. 31(1), 258\u2013261 (2003).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"3153_CR20","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13(11), 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"3153_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2007-8-9-r183","volume":"8","author":"DW Huang","year":"2007","unstructured":"Huang, D. W. et al. The DAVID gene functional classification tool: A novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 8, 1\u201316 (2007).","journal-title":"Genome Biol."},{"issue":"D1","key":"3153_CR22","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53(D1), D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"3153_CR23","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ijc.33283","volume":"148","author":"\u00c1 Nagy","year":"2021","unstructured":"Nagy, \u00c1. & Gy\u0151rffy, B. muTarget: A platform linking gene expression changes and mutation status in solid tumors. Int. J. Cancer. 148(2), 502\u2013511 (2021).","journal-title":"Int. J. Cancer."},{"issue":"W1","key":"3153_CR24","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48(W1), W509\u2013W514 (2020).","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"3153_CR25","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1289\/ehp.6028","volume":"111","author":"CJ Mattingly","year":"2003","unstructured":"Mattingly, C. J., Colby, G. T., Forrest, J. N. & Boyer, J. L. The comparative toxicogenomics database (CTD). Environ. Health Perspect. 111(6), 793\u2013795 (2003).","journal-title":"Environ. Health Perspect."},{"issue":"11 Pt 1","key":"3153_CR26","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1158\/1078-0432.CCR-05-2733","volume":"12","author":"MJ Fackler","year":"2006","unstructured":"Fackler, M. J. et al. Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin. Cancer Res. 12(11 Pt 1), 3306\u20133310 (2006).","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"3153_CR27","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/nmat4997","volume":"16","author":"RH Xu","year":"2017","unstructured":"Xu, R. H. et al. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. Nat. Mater. 16(11), 1155\u20131161 (2017).","journal-title":"Nat. Mater."},{"issue":"2","key":"3153_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/5947","volume":"21","author":"PA Jones","year":"1999","unstructured":"Jones, P. A. & Laird, P. W. Cancer epigenetics comes of age. Nat. Genet. 21(2), 163\u2013167 (1999).","journal-title":"Nat. Genet."},{"issue":"10","key":"3153_CR29","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nrc3130","volume":"11","author":"SB Baylin","year":"2011","unstructured":"Baylin, S. B. & Jones, P. A. A decade of exploring the cancer epigenome - biological and translational implications. Nat. Rev. Cancer. 11(10), 726\u2013734 (2011).","journal-title":"Nat. Rev. Cancer."},{"issue":"21","key":"3153_CR30","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1056\/NEJMra023075","volume":"349","author":"JG Herman","year":"2003","unstructured":"Herman, J. G. & Baylin, S. B. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349(21), 2042\u20132054 (2003).","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"3153_CR31","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0002-9440(10)63156-2","volume":"164","author":"T Etoh","year":"2004","unstructured":"Etoh, T. et al. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am. J. Pathol. 164(2), 689\u2013699 (2004).","journal-title":"Am. J. Pathol."},{"issue":"7","key":"3153_CR32","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cell.2022.02.021","volume":"185","author":"R Nalio Ramos","year":"2022","unstructured":"Nalio Ramos, R. et al. Tissue-resident FOLR2(+) macrophages associate with CD8(+) T cell infiltration in human breast cancer. Cell 185(7), 1189-1207.e25 (2022).","journal-title":"Cell"},{"key":"3153_CR33","doi-asserted-by":"crossref","unstructured":"Gochhait S, Bukhari SI, Bamezai R. mRNA Quantitation Using Real Time PCR. 2007 : 53\u201372.","DOI":"10.1007\/978-3-540-70865-0_4"},{"issue":"6","key":"3153_CR34","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1080\/08820139.2018.1480029","volume":"47","author":"P Zafari","year":"2018","unstructured":"Zafari, P. et al. Analysis of helios gene expression and Foxp3 TSDR methylation in the newly diagnosed rheumatoid arthritis patients. Immunol. Invest. 47(6), 632\u2013642 (2018).","journal-title":"Immunol. Invest."},{"issue":"9","key":"3153_CR35","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/ng1861","volume":"38","author":"SL Carter","year":"2006","unstructured":"Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N. & Szallasi, Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 38(9), 1043\u20131048 (2006).","journal-title":"Nat. Genet."},{"issue":"1","key":"3153_CR36","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin. 70(1), 7\u201330 (2020).","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"3153_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174357","volume":"12","author":"EJ Yu","year":"2017","unstructured":"Yu, E. J. et al. LZTS2 and PTEN collaboratively regulate \u00df-catenin in prostatic tumorigenesis. PLoS ONE 12(3), e0174357 (2017).","journal-title":"PLoS ONE"},{"issue":"7","key":"3153_CR38","doi-asserted-by":"publisher","first-page":"101042831771131","DOI":"10.1177\/1010428317711314","volume":"39","author":"JL Huang","year":"2017","unstructured":"Huang, J. L., Liao, Y., Qiu, M. X., Li, J. & An, Y. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt\/\u03b2-catenin signaling pathway in clear cell renal cell carcinoma. Tumour Biol. 39(7), 1010428317711314 (2017).","journal-title":"Tumour Biol."},{"issue":"9","key":"3153_CR39","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1369\/0022155413495875","volume":"61","author":"QZ Cui","year":"2013","unstructured":"Cui, Q. Z. et al. Leucine zipper tumor suppressor 2 inhibits cell proliferation and regulates Lef\/Tcf-dependent transcription through Akt\/GSK3\u03b2 signaling pathway in lung cancer. J. Histochem. Cytochem. 61(9), 659\u2013670 (2013).","journal-title":"J. Histochem. Cytochem."},{"issue":"23","key":"3153_CR40","doi-asserted-by":"publisher","first-page":"8857","DOI":"10.1128\/MCB.01031-06","volume":"26","author":"G Thyssen","year":"2006","unstructured":"Thyssen, G. et al. LZTS2 is a novel beta-catenin-interacting protein and regulates the nuclear export of beta-catenin. Mol. Cell Biol. 26(23), 8857\u20138867 (2006).","journal-title":"Mol. Cell Biol."},{"issue":"7472","key":"3153_CR41","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nature12750","volume":"502","author":"RM Kohli","year":"2013","unstructured":"Kohli, R. M. & Zhang, Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature 502(7472), 472\u2013479 (2013).","journal-title":"Nature"},{"issue":"1","key":"3153_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto, M. A., Huang, R. Y., Jackson, R. A. & Thiery, J. P. EMT: 2016. Cell 166(1), 21\u201345 (2016).","journal-title":"Cell"},{"issue":"14","key":"3153_CR43","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.3390\/jcm12144646","volume":"12","author":"Y Sato","year":"2023","unstructured":"Sato, Y. et al. Novel biomarkers of gastric cancer: Current research and future perspectives. J. Clin. Med. 12(14), 4646 (2023).","journal-title":"J. Clin. Med."},{"key":"3153_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.901182","volume":"12","author":"GL Zheng","year":"2022","unstructured":"Zheng, G. L., Zhang, G. J., Zhao, Y. & Zheng, Z. C. Screening protein prognostic biomarkers for stomach adenocarcinoma based on the cancer proteome atlas. Front. Oncol. 12, 901182 (2022).","journal-title":"Front. Oncol."},{"key":"3153_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.617261","volume":"7","author":"M Nomden","year":"2020","unstructured":"Nomden, M., Beljaars, L., Verkade, H. J., Hulscher, J. & Olinga, P. Current concepts of biliary atresia and matrix metalloproteinase-7: A review of literature. Front. Med. (Lausanne). 7, 617261 (2020).","journal-title":"Front. Med. (Lausanne)."},{"issue":"1","key":"3153_CR46","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1186\/s12885-022-09633-x","volume":"22","author":"M Shabbir","year":"2022","unstructured":"Shabbir, M. et al. Association of CTLA-4 and IL-4 polymorphisms in viral induced liver cancer. BMC Cancer 22(1), 518 (2022).","journal-title":"BMC Cancer"},{"issue":"7869","key":"3153_CR47","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41586-021-03741-7","volume":"595","author":"H Jin","year":"2021","unstructured":"Jin, H. et al. EGFR activation limits the response of liver cancer to lenvatinib. Nature 595(7869), 730\u2013734 (2021).","journal-title":"Nature"},{"issue":"2","key":"3153_CR48","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1053\/j.gastro.2021.04.064","volume":"161","author":"NR Gough","year":"2021","unstructured":"Gough, N. R., Xiang, X. & Mishra, L. TGF-\u03b2 signaling in liver, pancreas, and gastrointestinal diseases and cancer. Gastroenterology 161(2), 434-452.e15 (2021).","journal-title":"Gastroenterology"},{"issue":"4","key":"3153_CR49","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/biom12040548","volume":"12","author":"S Zhang","year":"2022","unstructured":"Zhang, S. et al. Advanced strategies for therapeutic targeting of wild-type and mutant p53 in cancer. Biomolecules 12(4), 548 (2022).","journal-title":"Biomolecules"},{"issue":"1","key":"3153_CR50","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41401-024-01354-0","volume":"46","author":"CY Hou","year":"2024","unstructured":"Hou, C. Y. et al. Aristolochic acids-hijacked p53 promotes liver cancer cell growth by inhibiting ferroptosis. Acta Pharmacol. Sin. 46(1), 208\u2013221 (2024).","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"3153_CR51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13058-015-0514-2","volume":"17","author":"B Gy\u0151rffy","year":"2015","unstructured":"Gy\u0151rffy, B. et al. Multigene prognostic tests in breast cancer: Past, present, future. Breast Cancer Res. 17(1), 11 (2015).","journal-title":"Breast Cancer Res."},{"issue":"12","key":"3153_CR52","doi-asserted-by":"publisher","first-page":"16541","DOI":"10.18632\/aging.203175","volume":"13","author":"J Li","year":"2021","unstructured":"Li, J. et al. Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment. Aging (Albany NY). 13(12), 16541\u201316566 (2021).","journal-title":"Aging (Albany NY)."},{"issue":"6","key":"3153_CR53","first-page":"2572","volume":"13","author":"X Yu","year":"2023","unstructured":"Yu, X. et al. ELL associated factor 2 is a potential diagnostic and prognostic indicator: evidence from the in silico and in vitro experiments. Am. J. Cancer Res. 13(6), 2572\u20132587 (2023).","journal-title":"Am. J. Cancer Res."},{"issue":"14","key":"3153_CR54","doi-asserted-by":"publisher","first-page":"7379","DOI":"10.1093\/nar\/gky615","volume":"46","author":"R Shanmugam","year":"2018","unstructured":"Shanmugam, R. et al. SRSF9 selectively represses ADAR2-mediated editing of brain-specific sites in primates. Nucleic Acids Res. 46(14), 7379\u20137395 (2018).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"3153_CR55","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12943-018-0864-3","volume":"17","author":"M Yi","year":"2018","unstructured":"Yi, M. et al. Biomarkers for predicting efficacy of PD-1\/PD-L1 inhibitors. Mol. Cancer. 17(1), 129 (2018).","journal-title":"Mol. Cancer."},{"issue":"4","key":"3153_CR56","first-page":"307","volume":"24","author":"G Mazur","year":"1993","unstructured":"Mazur, G. & Frydecka, I. Interleukin 2 (IL-2) and its receptor (IL-2R) in healthy individuals and with various disease states. Acta Haematol. Pol. 24(4), 307\u2013313 (1993).","journal-title":"Acta Haematol. Pol."},{"issue":"2","key":"3153_CR57","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrc.2016.2","volume":"16","author":"NP Restifo","year":"2016","unstructured":"Restifo, N. P., Smyth, M. J. & Snyder, A. Acquired resistance to immunotherapy and future challenges. Nat. Rev. Cancer. 16(2), 121\u2013126 (2016).","journal-title":"Nat. Rev. Cancer."},{"issue":"2","key":"3153_CR58","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","volume":"51","author":"RM Samstein","year":"2019","unstructured":"Samstein, R. M. et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat. Genet. 51(2), 202\u2013206 (2019).","journal-title":"Nat. Genet."},{"issue":"21","key":"3153_CR59","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/jnci\/djs427","volume":"104","author":"AD Roth","year":"2012","unstructured":"Roth, A. D. et al. Integrated analysis of molecular and clinical prognostic factors in stage II\/III colon cancer. J. Natl. Cancer Inst. 104(21), 1635\u20131646 (2012).","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03153-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03153-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03153-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:05:19Z","timestamp":1759791919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03153-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3153"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03153-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article Xiaoyan Chen was incorrectly only affiliated with \u2018<sup>3<\/sup>Department of Radiation Oncology, Cancer Center, Zhejiang Provincial People\u2019s Hospital (Affiliated People\u2019s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.\u2019. The correct affiliation\u2019s are listed here:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1. Department of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3. Department of Radiation Oncology, Cancer Center, Zhejiang Provincial People\u2019s Hospital (Affiliated People\u2019s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17873"}}